Clinical Trials Browser

Has results × MK 2206 × Head & Neck × Clear all

NCT01604772 2019-05-01

Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma

Phase 2 Completed

16 enrolled 7 charts

Salivary Gland Neoplasms

NCT01349933 2017-12-05

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

21 enrolled 11 charts

Recurrent Squamous Cell Carcinoma of the Nasopharynx